Gu, M., Xu, T., & Chang, P. (2021). KRAS/LKB1 and KRAS/TP53 co-mutations create divergent immune signatures in lung adenocarcinomas. Ther Adv Med Oncol.
शिकागो स्टाइल उद्धरणGu, Meichen, Tiankai Xu, और Pengyu Chang. "KRAS/LKB1 and KRAS/TP53 Co-mutations Create Divergent Immune Signatures in Lung Adenocarcinomas." Ther Adv Med Oncol 2021.
एमएलए उद्धरणGu, Meichen, Tiankai Xu, और Pengyu Chang. "KRAS/LKB1 and KRAS/TP53 Co-mutations Create Divergent Immune Signatures in Lung Adenocarcinomas." Ther Adv Med Oncol 2021.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.